A 55-year-old man with newly diagnosed type 2 diabetes (A1C 8.4%) has no clinical atherosclerotic cardiovascular disease, chronic kidney disease, or other major comorbidities. His LDL-C is 3.0 mmol/L. According to the 2021 Canadian Cardiovascular Society dyslipidemia guideline, which of the following best describes the recommended lipid management?